Particle Therapy Market Expansion Continues, with Forecast Valuation of $2.16 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Particle Therapy Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the particle therapy market has experienced fast-paced growth. It's anticipated that the market size will jump from $1.23 billion in 2024 to $1.36 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.0%. This accelerated growth during the historic period is a result of various factors, such as clinical research and investigations, a rise in cancer cases, government backing and financial assistance, collaboration within the industry, and enhancement in treatment planning.

Particle Therapy Market Size Forecast: What's the Projected Valuation by 2029?
The market size for particle therapy is predicted to experience a swift expansion in the coming years, reaching $2.16 billion in 2029, with a compound annual growth rate (CAGR) of 12.3%. This projected growth during the forecast period is due to factors such as increasing expenditure on healthcare, the development of new non-cancer applications, a growing elderly demographic, the improvement of healthcare infrastructure, and the integration of AI and data analytics. Key trends forecasted for this period include the enhancement of particle accelerator technology, the rise of hypofractionation techniques, the combination therapy of proton and carbon ion, enhancements in patient comfort, and the formulation of treatment protocols centred around biology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/particle-therapy-global-market-report

What Are the Drivers Transforming the Particle Therapy Market?
The increasing occurrence of cancer is anticipated to drive the expansion of the particle therapy market. Cancer denotes a range of diseases characterized by unusual cell proliferation in the body. Particle therapy primarily focuses on cancer treatment using precise and efficacious radiation, where protons (positively charged particles) are accelerated to high velocities and then directed at the tumor. For example, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported in April 2024 that approximately 20 million new cancer cases were recorded in 2022, leading to almost 10 million fatalities as a result of the condition. Projections based on demographic trends suggest an increase in the annual count of new cancer cases, potentially reaching 35 million by 2050, a 77% rise from the figures in 2022. Consequently, the increasing prevalence of cancer is fostering the expansion of the particle therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12250&type=smp

What Are the Key Trends Driving Particle Therapy Market Growth?
The rise of advanced particle therapy platforms represents a key trend in the particle therapy market. To maintain their market position, leading companies are innovating and developing these platforms. For example, RaySearch Laboratories, a medical technology firm based in Sweden, launched the RayStation 2023B in July 2023. This holistic cancer treatment planning system includes several groundbreaking enhancements in particle therapy, such as backing for discrete proton arcs and robust optimization grounded on linear energy transfer (LET). LET optimization serves to limit potential side effects by lowering LET in risk organs and directing high LET particles towards tumors to enhance tumor control. Additionally, the optimization of discrete proton arc allows for a wider range of beam angles, resulting in more precise dose distributions and minimized exposure for risk organs. Moreover, the software provides an easy transition to standard pencil-beam scanning plans, automatic field-in-field planning for photons, point-based optimization for brachytherapy, and accelerated data loading speeds.

Which Segments in the Particle Therapy Market Offer the Most Profit Potential?
The particle therapy market covered in this report is segmented -

1) By Type: Proton Therapy, Heavy Ion Therapy
2) By System: Single-Room Systems, Multi-Room Systems
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
4) By End-User: Hospital, Academic And Research Centers

Subsegments:
1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)
2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy, Other Heavy Ions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12250&type=smp

Which Firms Dominate the Particle Therapy Market by Market Share and Revenue in 2025?
Major companies operating in the particle therapy market include Hitachi Ltd., Mitsubishi Electric Corporation, Siemens Healthineers AG, Koninklijke Philips N.V, GE Healthcare, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Shinva Medical Instrument Co. Ltd., Toshiba Medical Systems Corporation, Brainlab AG, Accuray Incorporated, IBA Worldwide, Mevion Medical Systems Inc., Avante Health Solutions, Provision Healthcare LLC, ViewRay, Panacea Biotec Ltd., PTW Freiburg GmbH., ProNova Solutions LLC, Optivus Proton Therapy Inc., Xstrahl Inc., Protom International Inc., Danfysik AS, SAH Global LLC, Advanced Oncotherapy plc, Particle Therapy Co-Operative Group, Best Particle Therapy Inc.

Which Regions Offer the Highest Growth Potential in the Particle Therapy Market?
North America was the largest region in the particle therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12250

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.